| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brighter future for malaria prevention?
|
The Lancet Infectious Diseases,
|
|
|
21 |
10 |
p. 1333
|
artikel
|
| 2 |
Acute flaccid paralysis in a young woman
|
Zawadzka, Sabina
|
|
|
21 |
10 |
p. 1470
|
artikel
|
| 3 |
Arterolane-based combinations for the treatment of uncomplicated falciparum malaria in Kenyan children
|
Varo, Rosauro
|
|
|
21 |
10 |
p. 1338-1339
|
artikel
|
| 4 |
Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
|
Hamaluba, Mainga
|
|
|
21 |
10 |
p. 1395-1406
|
artikel
|
| 5 |
Australia's struggle with the delta variant
|
Kenyon, Georgina
|
|
|
21 |
10 |
p. 1358
|
artikel
|
| 6 |
Blood and steel: an ode to the past, a warning for the future
|
Cooper, Bethany
|
|
|
21 |
10 |
p. 1363
|
artikel
|
| 7 |
Booster shots for COVID-19—the debate continues
|
Burki, Talha
|
|
|
21 |
10 |
p. 1359-1360
|
artikel
|
| 8 |
Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study
|
Bettuzzi, Thomas
|
|
|
21 |
10 |
p. 1441-1447
|
artikel
|
| 9 |
Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study
|
Adekoya, Itunuoluwa
|
|
|
21 |
10 |
p. 1429-1440
|
artikel
|
| 10 |
CoronaVac induces lower neutralising activity against variants of concern than natural infection
|
Vacharathit, Vimvara
|
|
|
21 |
10 |
p. 1352-1354
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2021; 21: 962–74
|
|
|
|
21 |
10 |
p. e302
|
artikel
|
| 12 |
Correction to Lancet Infect Dis 2021; 21: e209–e21
|
|
|
|
21 |
10 |
p. e302
|
artikel
|
| 13 |
Correction to Lancet Infect Dis 2021; published online May 26. https://doi.org/10.1016/S1473-3099(20)30857-4
|
|
|
|
21 |
10 |
p. e302
|
artikel
|
| 14 |
Disseminated Talaromyces marneffei infection mimicking intestinal tuberculosis
|
Yang, Yuhua
|
|
|
21 |
10 |
p. 1469
|
artikel
|
| 15 |
Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial
|
Ali, Mohammad
|
|
|
21 |
10 |
p. 1407-1414
|
artikel
|
| 16 |
Elimination of cervical cancer depends on HPV vaccination and primary HPV screening
|
Harper, Diane M
|
|
|
21 |
10 |
p. 1342-1344
|
artikel
|
| 17 |
Facing leprosy in the 1920s
|
Bagcchi, Sanjeet
|
|
|
21 |
10 |
p. 1364
|
artikel
|
| 18 |
Food for thought: addressing undernutrition to end tuberculosis
|
Sinha, Pranay
|
|
|
21 |
10 |
p. e318-e325
|
artikel
|
| 19 |
Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
|
Bager, Peter
|
|
|
21 |
10 |
p. 1351
|
artikel
|
| 20 |
Human papillomavirus vaccinations matter!
|
van der Sande, Marianne A B
|
|
|
21 |
10 |
p. 1341-1342
|
artikel
|
| 21 |
Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial
|
Licciardi, Paul Vincent
|
|
|
21 |
10 |
p. 1415-1428
|
artikel
|
| 22 |
Infectious diseases in Afghanistan: a dismal scenario
|
Bagcchi, Sanjeet
|
|
|
21 |
10 |
p. 1357
|
artikel
|
| 23 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
10 |
p. 1360
|
artikel
|
| 24 |
Innovations in COVID-19 testing: the road from pandemic response to control
|
Peeling, Rosanna W
|
|
|
21 |
10 |
p. 1334-1335
|
artikel
|
| 25 |
Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
|
Tempe, Deepak K
|
|
|
21 |
10 |
p. 1349-1350
|
artikel
|
| 26 |
Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? – Authors' reply
|
Udwadia, Zarir
|
|
|
21 |
10 |
p. 1350
|
artikel
|
| 27 |
Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?
|
Todsen, Tobias
|
|
|
21 |
10 |
p. 1348
|
artikel
|
| 28 |
Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – Authors' reply
|
Tsang, Nicole Ngai Yung
|
|
|
21 |
10 |
p. 1348-1349
|
artikel
|
| 29 |
Moving forward with an imperfect vaccine
|
Pezzoli, Lorenzo
|
|
|
21 |
10 |
p. 1339-1341
|
artikel
|
| 30 |
Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks
|
Guilamo-Ramos, Vincent
|
|
|
21 |
10 |
p. e326-e333
|
artikel
|
| 31 |
Performance of saliva and mid-turbinate swabs for detection of the beta variant in South Africa
|
Chu, Chun Yat
|
|
|
21 |
10 |
p. 1354
|
artikel
|
| 32 |
Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
|
Moran, Ed
|
|
|
21 |
10 |
p. 1345-1347
|
artikel
|
| 33 |
Post-acute conditions of patients with COVID-19 not requiring hospital admission
|
Huang, Lixue
|
|
|
21 |
10 |
p. 1335-1336
|
artikel
|
| 34 |
Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study
|
Lund, Lars Christian
|
|
|
21 |
10 |
p. 1373-1382
|
artikel
|
| 35 |
Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study
|
Chow, Eric P F
|
|
|
21 |
10 |
p. 1448-1457
|
artikel
|
| 36 |
Quantifying the rates of late reactivation tuberculosis: a systematic review
|
Dale, Katie D
|
|
|
21 |
10 |
p. e303-e317
|
artikel
|
| 37 |
Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
|
Snell, Luke B
|
|
|
21 |
10 |
p. 1351-1352
|
artikel
|
| 38 |
Recombinant protein vaccines against SARS-CoV-2
|
Gilbert, Sarah C
|
|
|
21 |
10 |
p. 1337-1338
|
artikel
|
| 39 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
10 |
p. 1361
|
artikel
|
| 40 |
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
|
Chappell, Keith J
|
|
|
21 |
10 |
p. 1383-1394
|
artikel
|
| 41 |
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial
|
Revollo, Boris
|
|
|
21 |
10 |
p. 1365-1372
|
artikel
|
| 42 |
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials
|
Mariz, Filipe Colaço
|
|
|
21 |
10 |
p. 1458-1468
|
artikel
|
| 43 |
Testing indicators to monitor the COVID-19 pandemic
|
Beauté, Julien
|
|
|
21 |
10 |
p. 1344-1345
|
artikel
|
| 44 |
Treatment of disseminated nocardiosis: a host–pathogen approach with adjuvant interferon gamma
|
Derungs, Thomas
|
|
|
21 |
10 |
p. e334-e340
|
artikel
|
| 45 |
Updates on management of STIs
|
Mushtaq, Ammara
|
|
|
21 |
10 |
p. 1356
|
artikel
|
| 46 |
Vaccinating children: fairness and childism
|
Autzen, Bengt
|
|
|
21 |
10 |
p. 1354-1355
|
artikel
|
| 47 |
Van-Mai Cao-Lormeau—putting Pacific Islands on the map
|
Kirby, Tony
|
|
|
21 |
10 |
p. 1362
|
artikel
|
Tijdschrift beschrijving